TheraRadar
Clinical-Stage Companies / HK inno.N Corporation

HK inno.N Corporation

Pre-Approval PRO BETA
69
Total Trials
16
Phase 3
2
Phase 2
1
Recruiting
419
Score

Pipeline by Phase

Phase 3
16
Phase 2
2
Phase 1
46

Therapeutic Focus

Healthy Erosive Esophagitis Diabetes Mellitus Hypertension Helicobacter Pylori Infection

Clinical Trials (69)

NCT07308184 Phase 3 NOT YET RECRUITING

Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

Started: 12/1/2025

NCT07192263 Phase 3 NOT YET RECRUITING

Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

Started: 9/22/2025

NCT05337228 Phase 3 COMPLETED

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301

Started: 8/9/2022

NCT05299099 Phase 3 COMPLETED

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

Started: 5/4/2022

NCT02368665 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

Started: 12/1/2014

NCT02368652 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Started: 12/1/2014

NCT04022096 Phase 3 COMPLETED

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis

Started: 6/18/2019

NCT03317223 Phase 3 COMPLETED

A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients

Started: 10/17/2017

NCT04128917 Phase 3 COMPLETED

Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT

Started: 1/21/2020

NCT03498456 Phase 3 COMPLETED

Triple Therapy With Tegoprazan in H. Pylori Positive Patients

Started: 6/28/2018

NCT02761512 Phase 3 COMPLETED

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer

Started: 5/1/2016

NCT03536598 Phase 3 COMPLETED

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

Started: 10/14/2016

NCT02556021 Phase 3 COMPLETED

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease

Started: 9/22/2015

NCT03006874 Phase 3 COMPLETED

Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

Started: 5/2/2016

NCT02456935 Phase 3 COMPLETED

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

Started: 5/1/2015

NCT01370707 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients

Started: 4/1/2011

NCT07073677 Phase 2 NOT YET RECRUITING

A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients

Started: 7/1/2025

NCT02028663 Phase 2 COMPLETED

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

Started: 5/1/2013

NCT07311811 Phase 1 NOT YET RECRUITING

A Study to Evaluate the Pharmacokinetics and Safety of IN-M00007 and IN-R00007 in Healthy Adult Volunteers

Started: 1/1/2026

NCT07277712 Phase 1 NOT YET RECRUITING

A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers

Started: 12/27/2025

NCT06736912 Phase 1 NOT YET RECRUITING

This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants

Started: 12/16/2024

NCT06725355 Phase 1 ACTIVE NOT RECRUITING

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

Started: 8/16/2024

NCT05723510 Phase 1 COMPLETED

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

Started: 3/6/2023

NCT05005065 Phase 1 COMPLETED

Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

Started: 9/6/2021

NCT05040880 Phase 1 COMPLETED

A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers

Started: 7/8/2021

NCT04486157 Phase 1 COMPLETED

Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects

Started: 3/18/2021

NCT04654078 Phase 1 COMPLETED

Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

Started: 1/18/2021

NCT04654065 Phase 1 COMPLETED

Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers

Started: 1/4/2021

NCT04221321 Phase 1 COMPLETED

Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers

Started: 1/7/2020

NCT04231136 Phase 1 COMPLETED

Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers

Started: 1/14/2020

NCT04639804 Phase 1 COMPLETED

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

Started: 6/6/2020

NCT04171687 Phase 1 COMPLETED

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Started: 10/21/2019

NCT03814642 Phase 1 COMPLETED

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

Started: 1/21/2019

NCT04066257 Phase 1 COMPLETED

Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers

Started: 1/17/2019

NCT03863938 Phase 1 COMPLETED

Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male Subjects

Started: 3/27/2019

NCT03657472 Phase 1 COMPLETED

Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

Started: 9/19/2016

NCT03639493 Phase 1 COMPLETED

Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Started: 4/6/2018

NCT03542916 Phase 1 COMPLETED

Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

Started: 10/1/2014

NCT03378284 Phase 1 COMPLETED

A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers

Started: 12/10/2017

NCT02069821 Phase 1 COMPLETED

Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

Started: 3/1/2014

NCT03011996 Phase 1 COMPLETED

To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration

Started: 5/1/2016

NCT03043521 Phase 1 COMPLETED

Pharmacodynamic Properties of CJ-12420 on Evening Dosing

Started: 5/13/2015

NCT03009760 Phase 1 COMPLETED

To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose Administration

Started: 1/1/2015

NCT03009474 Phase 1 COMPLETED

Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

Started: 2/1/2015

NCT01501435 Phase 1 COMPLETED

To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra

Started: 12/1/2011

NCT02378441 Phase 1 COMPLETED

Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg

Started: 2/1/2015

NCT02185066 Phase 1 COMPLETED

Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR

Started: 7/1/2014

NCT02160743 Phase 1 COMPLETED

The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects

Started: 5/1/2014

NCT01925300 Phase 1 WITHDRAWN

Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin

Started: 7/1/2013

NCT02146625 Phase 1 COMPLETED

Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects

Started: 11/1/2014

NCT02060019 Phase 1 COMPLETED

Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects

Started: 3/1/2014

NCT02995239 Phase 1 COMPLETED

A Study to Compare the Pharmacokinetic Characteristics of CJ-12420

Started: 4/1/2015

NCT02052336 Phase 1 COMPLETED

Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects

Started: 10/1/2013

NCT01735890 Phase 1 COMPLETED

Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

Started: 9/1/2012

NCT01926548 Phase 1 COMPLETED

to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers

Started: 2/1/2012

NCT01925313 Phase 1 COMPLETED

A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers

Started: 12/1/2012

NCT01830309 Phase 1 COMPLETED

Food-Effect on PK and PD of Single Oral Dose of CJ-12420 in Healthy Male Subjects

Started: 1/1/2013

NCT01473173 Phase 1 COMPLETED

Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects

Started: 11/1/2011

NCT01765023 Phase 1 COMPLETED

Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects

Started: 10/1/2012

NCT01039896 Phase 1 COMPLETED

A Drug Interaction Study of SLM0807 and HKB0701 in Healthy Subjects

Started: 6/1/2009

NCT01489774 Phase 1 COMPLETED

Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects

Started: 5/1/2011

NCT01494727 Phase 1 COMPLETED

Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

Started: 2/1/2012

NCT01380873 Phase 1 COMPLETED

A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy Subject

Started: 1/1/2010

NCT01370681 Phase 1 COMPLETED

A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy Subject

Started: 10/1/2009

NCT05267743 Phase 4 COMPLETED

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease

Started: 2/16/2021

NCT03847506 Phase 4 COMPLETED

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

Started: 7/5/2018

NCT04309916 Phase 4 COMPLETED

Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

Started: 5/22/2020

NCT02137993 Phase 4 COMPLETED

Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia

Started: 3/1/2012

NCT01765452 Phase 4 COMPLETED

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Started: 10/1/2012

Drug Candidates

IN-R00007 IN-M00007 IN-B00009 Placebo Tegoprazan Naproxen IN-M00002 IN-115314 Ointment 1% IN-115314 Ointment 3% IN-115314 Ointment placebo
Activity Status: Active
Last Trial Started: 1/1/2026
Last Trial Ended: 7/24/2023
Trials (12 months): 5
Completed Trials: 61
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.